Succinylcholine and postoperative pulmonary complications: a retrospective cohort study using registry data from two hospital networks
- PMID: 32654742
- DOI: 10.1016/j.bja.2020.05.059
Succinylcholine and postoperative pulmonary complications: a retrospective cohort study using registry data from two hospital networks
Abstract
Background: Neuromuscular blocking agents (NMBAs) with a non-depolarising mechanism of action carry the risk of postoperative residual paralysis and are associated with postoperative pulmonary complications (POPC). Owing to the shorter duration of action, the depolarising NMBA succinylcholine may be associated with less postoperative residual paralysis, and hence fewer POPC. We tested the association of succinylcholine administration during anaesthesia and POPC.
Methods: In a retrospective cohort study of registry data from two large US academic medical centres, 244 850 adult noncardiac surgical patients undergoing general anaesthesia were included. The primary outcome was POPC, defined as post-extubation haemoglobin oxygen de-saturation to <90%, or re-intubation requiring intensive care unit admission within 7 days after surgery. The association between succinylcholine and POPC and its dose-dependency were tested in a hierarchical fashion using a multivariable logistic regression model.
Results: A total of 13 206 patients (5.4%) experienced POPC. Use of succinylcholine was associated with increased risk of POPC (adjusted odds ratio [ORAdj]=1.11; 95% confidence interval [CI], 1.06-1.16; P<0.001; adjusted risk=5.18%; 95% CI, 5.06-5.30 without and 5.69%; 95% CI, 5.53-5.85 with succinylcholine), with a dose-dependent relationship (ORAdj=1.08; 95% CI, 1.05-1.11 per mg kg-1; P<0.001). In patients receiving non-depolarising NMBAs, succinylcholine further increased the risk of POPC (ORAdj=1.08; 95% CI, 1.03-1.14; P=0.001). The association between succinylcholine and POPC was modified (P=0.03 for interaction) by the duration of surgery with higher odds of POPC in patients undergoing surgeries of <2 vs ≥2 h (ORAdj=1.24; 95% CI, 1.15-1.33 and 1.05; 95% CI, 1.00-1.10, respectively).
Conclusions: In contrast to our prediction, succinylcholine administration was associated with an increased risk of POPC. This association was dose-dependent and magnified in surgeries of shorter duration.
Keywords: dose–response relationship; general anaesthesia; hypoxaemia; neuromuscular blocking agent; respiratory failure; succinylcholine.
Copyright © 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Another nail in the coffin of succinylcholine?Br J Anaesth. 2020 Oct;125(4):423-425. doi: 10.1016/j.bja.2020.06.025. Epub 2020 Jul 15. Br J Anaesth. 2020. PMID: 32682561 No abstract available.
-
Not another requiem for succinylcholine. Comment on Br J Anaesth 2020; 125: 423-5.Br J Anaesth. 2020 Oct;125(4):e349-e350. doi: 10.1016/j.bja.2020.07.007. Epub 2020 Aug 1. Br J Anaesth. 2020. PMID: 32747076 No abstract available.
-
Routine neuromuscular monitoring before succinylcholine. Comment on Br J Anaesth 2020; 125: 629-36.Br J Anaesth. 2021 Mar;126(3):e103-e104. doi: 10.1016/j.bja.2020.12.022. Epub 2021 Jan 19. Br J Anaesth. 2021. PMID: 33478731 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
